Search - tctmd.com

Displaying 41 - 56 of 56

Sort: Relevancy | Date

News Conference News EuroPCR 2022

Intravascular Imaging Boosts Outcomes in Left Main PCI: ROLEX

Michael O'Riordan

May 18, 2022

News Conference News EuroPCR 2022

Shorter DAPT Sufficient Even in Complex HBR Patients: MASTER DAPT

Yael L. Maxwell

May 17, 2022

News Daily News

Flu Vaccines Reduce MACE, Especially in ACS: Meta-analysis

Yael L. Maxwell

May 06, 2022

News Daily News

NCDR Analyses Offer Insights Into First-Generation Watchman Outcomes

L.A. McKeown

May 03, 2022

News Conference News HRS 2022

Racial/Ethnic Disparities in Anticoagulation Persist in Hospitalized AF Patients

Todd Neale

April 29, 2022

News Daily News

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

Caitlin E. Cox

April 15, 2022

News Conference News ACC 2022

Managing AF Patients Undergoing PCI—Some Lingering Questions

Michael O'Riordan

April 12, 2022

News Conference News ACC 2022

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

Todd Neale

April 05, 2022

Presentation ACC 2022

Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial

Presenter: Duk-Woo Park

April 04, 2022

News Daily News

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Michael O'Riordan

March 30, 2022

News Opinion CV Team Dispatch

March 2022 News Roundup

L.A. McKeown

March 01, 2022

News Conference News STS 2022

Decades of Real-world Data Affirm Benefit of Multiple Arterial CABG

Yael L. Maxwell

February 03, 2022

News Opinion CV Team Dispatch

February 2022 News Roundup

L.A. McKeown

February 01, 2022

News Daily News

Before and After PCI, Women Have Poorer Health Status Than Men

L.A. McKeown

January 28, 2022

News Opinion CV Team Dispatch

January 2022 News Roundup

L.A. McKeown

January 01, 2022

Video

» Interview

A Randomized ADAPT-TAVR Trial: Edoxaban Versus Dual Antiplatelet Therapy for Valve Thrombosis and Cerebral Thromboembolism After Transcatheter Aortic-Valve Replacement

May 4, 2022

Advertisement

Intravascular Imaging Boosts Outcomes in Left Main PCI: ROLEX

Shorter DAPT Sufficient Even in Complex HBR Patients: MASTER DAPT

Flu Vaccines Reduce MACE, Especially in ACS: Meta-analysis

NCDR Analyses Offer Insights Into First-Generation Watchman Outcomes

Racial/Ethnic Disparities in Anticoagulation Persist in Hospitalized AF Patients

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

Managing AF Patients Undergoing PCI—Some Lingering Questions

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

March 2022 News Roundup

Decades of Real-world Data Affirm Benefit of Multiple Arterial CABG

February 2022 News Roundup

Before and After PCI, Women Have Poorer Health Status Than Men

January 2022 News Roundup

A Randomized ADAPT-TAVR Trial: Edoxaban Versus Dual Antiplatelet Therapy for Valve Thrombosis and Cerebral Thromboembolism After Transcatheter Aortic-Valve Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content